Скачать или смотреть Don't miss these ASX Healthcare stocks in September 2021

*Rhinomed has completed the development of the world's first nasal swab- The Rhinoswab JuniorTM- specifically designed for children.
*IDT Australia reported a record NPAT of AU$2.1 million, representing an improvement of 209.6% on year-on-year.
*Wellfully Limited has delivered material progress in FY21 across its product development pipeline.
*Neuren Pharmaceuticals progressing development of its NNZ-2591 to treat Angelman syndrome.
*Dimerix has commenced the Phase 3 clinical study (ACTION3) in patients with FSGS (focal segmental glomerulosclerosis).

#asx #healthcarestocks #neurenpharmaceuticals #wellfullylimited #IDTaustralialimited #healthcarestocks #dimerix

To get more updates about Australia, NZ, UK, Canada and US stock market news, investors education & insights, subscribe our channel at https://bit.ly/3cHKioy

Check out our media Website 👉 https://kalkinemedia.com/au
Follow us and stay updated on the Go with the Market Charter 👇👇
Facebook -   / kalkineau  
Twitter -   / kalkineau  
LinkedIn -   / 4829818